Goldman Sachs Group Inc Legend Biotech Corp Transaction History

Goldman Sachs Group Inc

$580 Billion
Q2 2024

A detailed history of Goldman Sachs Group Inc transactions in Legend Biotech Corp stock. As of the latest transaction made, Goldman Sachs Group Inc holds 667,990 shares of LEGN stock, worth $26.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

667,990

Previous 310,408 115.2%

Holding current value

$26.8 Million

Previous $17.4 Million 69.93%

% of portfolio

0.01%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$39.5 - $57.22 $14.1 Million - $20.5 Million	357,582 Added 115.2%	667,990 $29.6 Million
Q1 2024 May 15, 2024	SELL	$55.06 - $69.99 $11.7 Million - $14.9 Million	-212,259 Reduced 40.61%	310,408 $17.4 Million
Q4 2023 Feb 13, 2024	BUY	$57.25 - $69.74 $14.9 Million - $18.2 Million	260,899 Added 99.67%	522,667 $31.4 Million
Q3 2023 May 14, 2024	SELL	$63.16 - $76.5 $16.5 Million - $20 Million	-260,899 Reduced 49.92%	261,768 $17.6 Million
Q3 2023 Nov 14, 2023	SELL	$63.16 - $76.5 $8.05 Million - $9.75 Million	-127,433 Reduced 32.74%	261,768 $17.6 Million
Q2 2023 May 14, 2024	BUY	$46.28 - $75.01 $6.17 Million - $9.99 Million	133,215 Added 52.04%	389,201 $26.9 Million
Q2 2023 Aug 14, 2023	BUY	$46.28 - $75.01 $6.17 Million - $9.99 Million	133,215 Added 52.04%	389,201 $26.9 Million
Q1 2023 May 14, 2024	BUY	$43.42 - $57.37 $2.15 Million - $2.84 Million	49,583 Added 24.02%	255,986 $12.3 Million
Q1 2023 May 11, 2023	BUY	$43.42 - $57.37 $2.15 Million - $2.84 Million	49,583 Added 24.02%	255,986 $12.3 Million
Q4 2022 May 14, 2024	SELL	$38.8 - $55.46 $13.6 Million - $19.4 Million	-350,255 Reduced 62.92%	206,403 $10.3 Million
Q4 2022 Feb 13, 2023	SELL	$38.8 - $55.46 $13.6 Million - $19.4 Million	-350,255 Reduced 62.92%	206,403 $10.3 Million
Q3 2022 May 14, 2024	BUY	$38.15 - $57.1 $5.28 Million - $7.9 Million	138,330 Added 33.07%	556,658 $22.7 Million
Q3 2022 Nov 10, 2022	BUY	$38.15 - $57.1 $5.28 Million - $7.9 Million	138,330 Added 33.07%	556,658 $22.7 Million
Q2 2022 May 14, 2024	SELL	$33.54 - $55.0 $3.5 Million - $5.74 Million	-104,339 Reduced 19.96%	418,328 $23 Million
Q2 2022 Aug 15, 2022	BUY	$33.54 - $55.0 $1.73 Million - $2.83 Million	51,464 Added 14.03%	418,328 $23 Million
Q1 2022 May 16, 2022	BUY	$31.02 - $48.18 $4.59 Million - $7.12 Million	147,830 Added 67.49%	366,864 $13.3 Million
Q4 2021 Feb 14, 2022	BUY	$41.14 - $56.98 $5.93 Million - $8.22 Million	144,190 Added 192.65%	219,034 $10.2 Million
Q3 2021 Nov 10, 2021	BUY	$35.31 - $50.56 $2.64 Million - $3.78 Million	74,844 New	74,844 $3.78 Million

Others Institutions Holding LEGN

# of Institutions

212

Shares Held

77.9M

Call Options Held

412K

Put Options Held

387K

View Full List

About Legend Biotech Corp

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $6.73B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

More about LEGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Legend Biotech Corp Transaction History